Bill & Melinda Gates Foundation — Full Portfolio
5 tracked investments · listed companies and verified rows first
Neurosynaptic Communications develops the ReMeDi platform, a digital health solution combining point-of-care diagnostics, cloud-based healthcare management, and telemedicine technology for affordable healthcare access in rural and remote areas.
Digital HealthHealthtech
Stellapps builds the SmartMoo™ full-stack IoT platform that digitizes and optimizes milk production, procurement, and cold-chain management using sensors, big data, and machine learning.
AgTechFoodTechIoTSaaSBangalore, IN
Syntis Bio develops bioengineered polymer coatings for oral drug delivery, specifically targeting gastrointestinal tissues to enhance bioavailability of therapeutics in low-resource settings.
BiotechDeep TechDigital HealthBoston, US
Rahul Dhanda(Executive Officer, Director)Carlo Giovanni Traverso(Director)Robert Langer(Director)
BoardTeymour Boutros-Ghali(Director)TEYMOUR BOUTROS-GHALI(Director)Martin Madaus(Director)
Infinant Health develops a B. infantis probiotic pharmaceutical product (INF108, building on EVC001) aimed at preventing necrotizing enterocolitis (NEC) in preterm and very low birth weight infants in NICU care.
BiotechDigital HealthHealthtechWellness & FitnessSacramento, US
Michael Johnson(Executive Officer, Director)J. Bruce German(Co-founder)David Mills(Co-founder)Carlito Lebrilla(Co-founder)Daniela Barile(Co-founder)Samara Freeman(Co-founder & Director of Intellectual Property and Regulatory Affairs)
BiotechWatertown, US
Carlo Giovanni Traverso(Director)Zafi Avnur(Director)Amy W. Schulman(Executive Officer, Director)Edmund Harrigan(Director)Catherine Reynolds(Director)Robert S. Langer(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.